PMID- 37625530
OWN - NLM
STAT- MEDLINE
DCOM- 20240108
LR  - 20240108
IS  - 0003-4509 (Print)
IS  - 0003-4509 (Linking)
VI  - 82
IP  - 1
DP  - 2024 Jan
TI  - [Evaluation of the relevance of the pharmaceutical educational interview on the 
      knowledge and satisfaction of patients who received a vagus nerve neurostimulator 
      implantation].
PG  - 163-173
LID - S0003-4509(23)00099-8 [pii]
LID - 10.1016/j.pharma.2023.08.005 [doi]
AB  - INTRODUCTION: Vagal neurostimulation (VNS) medical devices (MDs) are used to 
      treat drug-resistant epilepsy. Using a magnet, the patient can activate on the 
      stimulations in order to stop a seizure or interrupt the adverse effects (AEs) of 
      the device. The objective is to evaluate the improvement of the patients' 
      knowledge about the VNS following a pharmaceutical educational interview (PEI) as 
      well as their satisfaction. MATERIALS AND METHODS: The pharmaceutical educational 
      interview regarding drugs and DMs was performed by the clinical pharmacist at the 
      patient's bed after VNS implantation. A questionnaire about VNS devices 
      (operation, adverse effects, recommendations) and assessing knowledge was 
      submitted to patients before and after the PEI. Satisfaction was assessed by the 
      Likert scale. RESULTS: From March 2020 to August 2021, 18 implanted patients were 
      included in the study. In 78% of cases (14/18), the total number of good 
      responses after PEI increased. The mean good response was significantly increased 
      from 16.11/25 (64%) before PEI to 22.33/25 (89%) after PEI (P-value<0.01). The 
      maximum satisfaction score (4/4) was given in 71% of the items. 
      DISCUSSION-CONCLUSION: The results support the relevance of PEI. Patients feel a 
      need for information and consider the interview useful. An improvement in 
      knowledge was observed, which allows us to hope for an optimization of the 
      effectiveness of the device, in particular, a reduction in seizures and AE. This 
      study shows the feasibility and the interest of the development of clinical 
      pharmacy applied to medical devices in complementarity with the expertise on 
      drugs.
CI  - Copyright (c) 2023 Academie Nationale de Pharmacie. Published by Elsevier Masson 
      SAS. All rights reserved.
FAU - Marqueyssat, Gael-Sean
AU  - Marqueyssat GS
AD  - Pole pharmacie, equipe de pole neurosciences et cephalique, CHU de Toulouse, 
      Toulouse, France. Electronic address: gs.marqueyssat@gmail.com.
FAU - Valton, Luc
AU  - Valton L
AD  - Explorations neurophysiologiques, CHU de Purpan, Toulouse, France; Centre de 
      recherche cerveau et cognition (CerCo), University of Toulouse, 31300 Toulouse, 
      France.
FAU - Civade, Elodie
AU  - Civade E
AD  - Pole pharmacie, equipe de pole neurosciences et cephalique, CHU de Toulouse, 
      Toulouse, France.
FAU - Laborde, Charlotte
AU  - Laborde C
AD  - Pole pharmacie, equipe de pole neurosciences et cephalique, I2MC equipe Ceramic, 
      UFR Sante service de Pharmacie clinique, CHU de Toulouse, Toulouse, France.
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Evaluation de la pertinence de l'entretien pharmaceutique educatif sur les 
      connaissances et la satisfaction de patients ayant beneficie d'une implantation 
      d'un neurostimulateur du nerf vague.
DEP - 20230823
PL  - France
TA  - Ann Pharm Fr
JT  - Annales pharmaceutiques francaises
JID - 2985176R
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Humans
MH  - Patient Satisfaction
MH  - *Vagus Nerve Stimulation/adverse effects/methods
MH  - *Drug Resistant Epilepsy/etiology/therapy
MH  - *Drug-Related Side Effects and Adverse Reactions
MH  - Vagus Nerve
MH  - Pharmaceutical Preparations
MH  - Treatment Outcome
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Entretiens pharmaceutiques
OT  - Epilepsy
OT  - Implantable neurostimulator
OT  - Neurochirurgie
OT  - Neurostimulateurs implantables
OT  - Neurostimulation du nerf vague
OT  - Neurosurgery
OT  - Pharmaceutical services
OT  - Pharmacie
OT  - Pharmacy
OT  - Vagus nerve stimulation
OT  - Epilepsie
EDAT- 2023/08/26 05:42
MHDA- 2024/01/08 06:42
CRDT- 2023/08/25 19:26
PHST- 2023/04/05 00:00 [received]
PHST- 2023/07/11 00:00 [revised]
PHST- 2023/08/21 00:00 [accepted]
PHST- 2024/01/08 06:42 [medline]
PHST- 2023/08/26 05:42 [pubmed]
PHST- 2023/08/25 19:26 [entrez]
AID - S0003-4509(23)00099-8 [pii]
AID - 10.1016/j.pharma.2023.08.005 [doi]
PST - ppublish
SO  - Ann Pharm Fr. 2024 Jan;82(1):163-173. doi: 10.1016/j.pharma.2023.08.005. Epub 
      2023 Aug 23.